COLORECTAL CANCER LIVER METASTASES (CRLM)

Clinical trials for COLORECTAL CANCER LIVER METASTASES (CRLM) explained in plain language.

Never miss a new study

Get alerted when new COLORECTAL CANCER LIVER METASTASES (CRLM) trials appear

Sign up with your email to follow new studies for COLORECTAL CANCER LIVER METASTASES (CRLM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1

New chemo combo aims to keep liver cancer from coming back after surgery

Disease control Not yet recruiting

This study tests a treatment for people whose colorectal cancer spread to the liver and was surgically removed. After surgery, participants get a liver-directed chemo drip plus standard chemo pills and IV drugs for 2 to 4 cycles. The goal is to see if this combination helps keep …

Matched conditions: COLORECTAL CANCER LIVER METASTASES (CRLM)

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated May 17, 2026 04:00 UTC

COLORECTAL CANCER LIVER METASTASES (CRLM)

Get alerted when new COLORECTAL CANCER LIVER METASTASES (CRLM) trials appear

New chemo combo aims to keep liver cancer from coming back after surgery